🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical study is to provide continued access to the study...
Status
Recruiting
Location
Helios Salud
Start Date
2024-08-27
Trial ID
NCT06337032
Treatments Being Tested
Mass balance study to determine the recovery of a single radiolabelled dose...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00828763
Treatments Being Tested
The LATA trial will find out if taking a long-acting injectable form of HIV...
Status
Unknown
Location
Moi University
Start Date
2023-06-22
Trial ID
NCT05154747
Treatments Being Tested
The goal of this clinical study is to learn more about the safety and dosin...
Status
Active Not Recruiting
Location
Pediatric Infectious Disease Associates
Start Date
2014-01-16
Trial ID
NCT02016924
Treatments Being Tested
Dolutegravir (DTG) is an HIV drug in the integrase inhibitor drug class. Th...
Status
Completed
Location
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program (Site ID: 4601)
Start Date
2011-04-20
Trial ID
NCT01302847
The purpose of this study was to evaluate the safety, tolerability, and pha...
Status
Completed
Location
USC - Maternal Child Adolescent/Adult Center
Start Date
2022-10-05
Trial ID
NCT05406583
This will be a randomized, partial-blind, placebo-controlled, single dose, ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09
Trial ID
NCT00996021
Treatments Being Tested
The First Long-Acting Injectable Regimen (FLAIR) study is being conducted t...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-10-27
Trial ID
NCT02938520
This is an open-label, single-center, single dose, non-randomized, sequenti...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-05-07
Trial ID
NCT03921723
Treatments Being Tested
This study aims to find the proposed dose of Rifapentine (RPT) taken once d...
Status
Not Yet Recruiting
Location
Gaborone (Site ID: 12701)
Start Date
2026-10-15
Trial ID
NCT07124559
Treatments Being Tested